Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925, Br J Cancer, vol.110, pp.2896-904, 2014. ,
Mechanisms of methotrexate resistance in osteosarcoma cell lines and strategies for overcoming this resistance, Oncol Lett, vol.9, issue.2, pp.940-944, 2015. ,
Mechanisms of therapy resistance in osteosarcoma: a review, Oncol Discov, pp.1-8, 2013. ,
miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo, Mol Oncol, vol.11, issue.2, pp.151-166, 2017. ,
,
MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial, J Clin Oncol, vol.33, issue.20, pp.2279-87, 2015. ,
Molecular mechanisms of chemoresistance in osteosarcoma (Review), Oncol Lett, vol.7, pp.1352-62, 2014. ,
Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort, Genes, Chromosom Cancer, vol.49, pp.40-51, 2010. ,
Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes, Br J Cancer, vol.109, pp.2228-2264, 2013. ,
Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice, Cancer Med, vol.7, issue.3, pp.665-676, 2018. ,
Characterization of Mouse Model-Derived Osteosarcoma (OS) Cells In Vitro and In Vivo, Methods Mol Biol, vol.26, pp.297-305, 2015. ,
Establishment and characterization of new orthotopic and metastatic neuroblastoma models, In Vivo, vol.28, pp.425-459, 2014. ,
Circular binary segmentation for the analysis of array-based DNA copy number data, Biostatistics, vol.5, pp.557-72, 2004. ,
Molecular Screening for Cancer Treatment Optimization ,
, Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial, Clin Cancer Res, vol.23, issue.20, pp.6101-6112, 2017.
Salmon provides fast and bias-aware quantification of transcript expression, Nat Methods, vol.14, pp.417-426, 2017. ,
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, vol.15, p.550, 2014. ,
Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells, Leuk Res, vol.36, pp.1315-1337, 2012. ,
Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma, PLoS One, vol.9, p.115835, 2014. ,
Single strand DNA binding proteins 1 and 2 protect newly replicated telomeres, Cell Res, vol.23, issue.5, pp.705-724, 2013. ,
The Role of Fas/FasL in the Metastatic Potential of Osteosarcoma and Targeting this Pathway for the Treatment of Osteosarcoma Lung Metastases, Cancer Treat Res, vol.152, pp.497-508, 2009. ,
Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells, Bone Joint Res, vol.6, pp.186-93, 2017. ,
Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line, PLoS One, vol.22, issue.4, p.95596, 2014. ,
Genetic and molecular characterization of the human Osteosarcoma 3AB-OS cancer stem cell line: A possible model for studying osteosarcoma origin and stemness, J Cell Physiol, vol.228, pp.1189-201, 2013. ,
Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma, Exp Mol Pathol, vol.84, pp.234-243, 2008. ,
Patient-derived osteosarcoma cells are resistant to methotrexate, PLoS One, vol.12, p.184891, 2017. ,
Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells, Ann Oncol, vol.15, pp.151-60, 2004. ,
Mechanisms of gene amplification and evidence of coamplification in drugresistant human osteosarcoma cell lines, Genes Chromosomes Cancer, vol.48, issue.4, pp.289-309, 2009. ,
Networking of differentially expressed genes in human cancer cells resistant to methotrexate, Genome Med, vol.1, issue.9, p.83, 2009. ,
Cisplatin-resistant osteosarcoma cells possess cancer stem cell properties in a mouse model ,
, Oncol Lett, vol.12, pp.2599-605, 2016.
Mechanisms and insights into drug resistance in cancer, Front Pharmacol, vol.4, p.28, 2013. ,
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma, Curr Cancer Drug Targets, vol.16, pp.261-74, 2016. ,
Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET, Clin Cancer Res, vol.20, pp.2959-70, 2014. ,
, , p.28
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial, Lancet Oncol, vol.17, pp.1070-80, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01702092
Relationship between RFC gene expression and intracellular drug concentration in methotrexate-resistant osteosarcoma cells, Genet Mol Res, vol.13, issue.3, pp.5313-5334, 2014. ,
Microenvironment Signals and Mechanisms in the Regulation of Osteosarcoma, Osteosarcoma -Biology, Behavior and Mechanisms ,
Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling, Am J Cancer Res, vol.7, issue.11, pp.2333-2349, 2017. ,
Establishment and characterization of multidrug-resistant human osteosarcoma cell lines, Anticancer Res, vol.13, pp.323-332, 1993. ,